Muscle-Invasive Bladder Cancer: Predictive Factors and Prognostic Difference Between Primary and Progressive Tumors

Urology

Volumn 70, Issue 3, 2007, Pages 477-481

  Türkölmez, Kadir ^a   Tokgöz, Hüsnü ^a   Reşorlu, Berkan ^a   Köse, Kenan ^a   Bedük, Yaşar ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; BLADDER MUSCLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; FEMALE; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; STATISTICAL SIGNIFICANCE; SURVIVAL TIME;

BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE PROGRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 34648829085     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.05.008     Document Type: Article

References (19)

1. Stein J.P., Lieskovsky G., Cote R., et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 19 (2001) 666-675
2. Vaidya A., Soloway M.S., Hawke C., et al. De novo muscle invasive bladder cancer: is there a change in trend?. J Urol 165 (2001) 47-50
3. May M., Helke C., Nitzke T., et al. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol Int 72 (2004) 103-111
4. Schrier B.P., Hollander M.P., Van Rhijn B.W., et al. Prognosis of muscle-invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 45 (2004) 292-296
5. Epstein J.I., Amin M.B., Reuter V.R., and Bladder Consensus Conference Committee of the World Health Organization/International Society of Urologic Pathology Consensus. Classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435-1448
6. Soloway MS: Re: Schrier BP, Hollander MP, Van Rhijn BWG, et al: Prognosis of muscle invasive bladder cancer: difference between primary and progressive tumours and implications for therapy. Eur Urol 47: 264, author reply 264, 2005.
7. Jimenez R.E., Gheiler E., Oskanian P., et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression free survival. Am J Surg Pathol 24 (2000) 980-987
8. Yu R.J., Stein J.P., Cai J., et al. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy. J Urol 176 (2006) 493-499
9. Angulo J.C., Lopez J.I., Flores N., et al. The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma: a critical revision of the 1987 TNM classification. J Cancer Res Clin Oncol 119 (1993) 578-593
10. Jordan A.M., Weingarten J., and Murphy W.M. Transitional cell neoplasms of the urinary bladder: can biologic potential be predicted from histologic grading?. Cancer 60 (1987) 2766-2774
11. Lipponen P.K., Eskelinen M.J., Kiviranta J., et al. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction. J Urol 146 (1991) 1535-1540
12. Mazzucchelli L., Bacchi M., Studer U.E., et al. Invasion depth is the most important prognostic factor for transitional cell carcinoma in a prospective trial of radical cystectomy and adjuvant chemotherapy. Int J Cancer 57 (1994) 15-20
13. Narayana A.S., Loening S.A., Slymen D.J., et al. Bladder cancer: factors affecting survival. J Urol 130 (1983) 56-60
14. Takashi M., Murase T., Mizuno S., et al. Multi-variate evaluation of prognostic determinants in bladder cancer patients. Urol Int 42 (1987) 368-374
15. Anderstrom C., Johansson S., and Nilsson S. The significance of lamina propria invasion on the prognosis of patients with bladder tumors. J Urol 124 (1980) 23-26
16. Logothetis C.J., Johnson D.E., Chong C., et al. Adjuvant cyclophosphamide, doxorubicin and cisplatin chemotherapy for bladder cancer: an update. J Clin Oncol 6 (1988) 1590-1596
17. Bassi P., Ferrante G.D., Piazza N., et al. Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort. J Urol 161 (1999) 1494-1497
18. Hara S., Miyake H., Fujisawa M., et al. Prognostic variables in patients who have undergone radical cystectomy for transitional cell carcinoma of the bladder. Jpn J Clin Oncol 31 (2001) 399-402
19. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539